Alixorexton is being explored as a potential treatment for narcolepsy. It has shown improvement in wakefulness in patients with narcolepsy type 1 at all doses. The development of Alixorexton appears to involve a biotech startup and may have originated from personal motivations, such as parents seeking to help their children.